CATALOGO DEI PRODOTTI DELLA RICERCA

BUSTI, Fabiana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.869
EU - Europa 3.519
AS - Asia 2.563
SA - Sud America 426
AF - Africa 93
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.482
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.780
RU - Federazione Russa 1.490
SG - Singapore 944
CN - Cina 726
GB - Regno Unito 589
IT - Italia 334
BR - Brasile 333
VN - Vietnam 258
HK - Hong Kong 229
SE - Svezia 224
DE - Germania 196
FR - Francia 172
IE - Irlanda 162
FI - Finlandia 138
KR - Corea 96
BD - Bangladesh 74
CA - Canada 52
JP - Giappone 46
IN - India 42
NL - Olanda 39
UA - Ucraina 35
AR - Argentina 34
BE - Belgio 27
ID - Indonesia 27
ZA - Sudafrica 23
ES - Italia 21
IQ - Iraq 21
TR - Turchia 20
MX - Messico 18
NG - Nigeria 16
PK - Pakistan 16
PL - Polonia 16
EC - Ecuador 12
AT - Austria 11
CL - Cile 11
IR - Iran 10
LT - Lituania 10
TG - Togo 10
VE - Venezuela 10
EG - Egitto 9
BJ - Benin 8
CZ - Repubblica Ceca 8
UZ - Uzbekistan 8
AU - Australia 7
CO - Colombia 7
BO - Bolivia 6
CH - Svizzera 6
GR - Grecia 6
JO - Giordania 6
DZ - Algeria 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
DO - Repubblica Dominicana 4
HR - Croazia 4
KG - Kirghizistan 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
PY - Paraguay 4
SA - Arabia Saudita 4
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
CY - Cipro 3
EU - Europa 3
HN - Honduras 3
PH - Filippine 3
RO - Romania 3
SN - Senegal 3
TN - Tunisia 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
DK - Danimarca 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
MT - Malta 2
MY - Malesia 2
PA - Panama 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
EE - Estonia 1
GY - Guiana 1
IM - Isola di Man 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
Totale 10.469
Salva come PNG Salva come JPEG
Città #
Moscow 505
Singapore 493
Ashburn 490
Southend 463
Chandler 416
San Jose 364
Dallas 301
Jacksonville 227
Hong Kong 220
Ann Arbor 164
Dublin 160
Beijing 138
Verona 136
New York 135
Woodbridge 130
The Dalles 104
Ho Chi Minh City 85
Los Angeles 83
Council Bluffs 82
Houston 66
Wilmington 66
Lawrence 59
Princeton 59
Munich 52
Helsinki 48
Jinan 43
Boardman 40
Nanjing 40
Tokyo 39
Hanoi 36
São Paulo 36
Buffalo 35
Redondo Beach 34
Santa Clara 32
Shenyang 27
Brussels 25
London 24
Orem 23
Turku 21
Lancaster 20
Redmond 20
Falkenstein 19
Tianjin 19
Haikou 18
Milan 18
Seoul 18
Sindelfingen 18
Zhengzhou 18
Brooklyn 17
Hebei 17
Columbus 16
Falls Church 16
Montreal 16
Nanchang 16
Ningbo 16
Chennai 15
Poplar 15
Rome 15
Seattle 15
Denver 14
Frankfurt am Main 14
San Francisco 14
Toronto 14
Abuja 13
Changsha 13
Warsaw 13
Bologna 12
Chicago 12
Guangzhou 12
Haiphong 12
Jakarta 12
Lappeenranta 12
Nuremberg 12
Amsterdam 11
Johannesburg 11
Rio de Janeiro 11
Taiyuan 11
Taizhou 11
Dhaka 10
Lomé 10
Redwood City 10
Atlanta 9
Boston 9
City of London 9
Fuzhou 9
Hangzhou 9
Jiaxing 9
Madrid 9
Phoenix 9
Charlotte 8
Cotonou 8
Da Nang 8
Norwalk 8
Tashkent 8
Vienna 8
Belo Horizonte 7
Lanzhou 7
Stockholm 7
Tehran 7
Villarbasse 7
Totale 6.262
Salva come PNG Salva come JPEG
Nome #
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 239
A challenging case of abdominal pain associated to Helicobacter pylori infection 238
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 209
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 206
HEPCIDIN SUPPRESSION IN BETA-THALASSEMIA CARRIERS WITH IRON OVERLOAD. Preliminary reports from an ongoing study. 206
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 205
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 204
Identification of new BMP6 pro-peptide mutations in patients with iron overload 201
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 199
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 196
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 194
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 191
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 190
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 190
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 189
Altered paraoxonase expression in patients with genetic haemochromatosis. 189
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 185
Genomics of coronary artery disease and myocardial infarction. From Genome Wide Association Studies to the Next-Generation-Sequencing era 180
Paraoxonase-1 status in patients with hereditary hemochromatosis 175
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 173
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis 172
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 167
COBALAMIN DEFICIENCY IN THE ELDERLY 166
Hepcidin suppression relative to iron status in patients with chronic Hepatitits C 163
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 161
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 159
Modern iron replacement therapy: clinical and pathophysiological insights 158
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 152
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.c282y homozygous patients. 151
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 151
Practical implications of the 2019 Nobel Prize in Physiology or Medicine: from molecular adaptation to hypoxia to novel anti-anemic drugs in the clinic 150
DISHphagia: An Unusual Cause of Dysphagia. J Clin Endocrinol Metab. 149
Iron replacement therapy: entering the new era without misconceptions, but more research is needed 145
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 145
An unusual case of inferior vena cava thrombosis: widening the differential diagnosis 143
Anemia and adverse outcomes in the elderly: a detrimental inflammatory loop? 141
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease but not with mortality in the setting of secondary prevention 136
Reduced serum hepcidin levels in patients with chronic hepatitis C 135
Iron replacement in inflammatory bowel disease: an evolving scenario 133
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 131
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach 127
Diagnosis and management of hereditary hemochromatosis: lifestyle modification, phlebotomy, and blood donation 125
Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting 123
Iron metabolism in infections: Focus on COVID-19 122
GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors 119
Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19? 119
Treatment options for anemia in the elderly 117
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 116
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches 115
Hyperferritinemia and diagnosis of type 1 Gaucher disease 114
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 113
Therapeutic oligonucleotides in cardiovascular and metabolic diseases: insights for the internist 109
Iron deficiency in the elderly population, revisited in the hepcidin era. 106
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 106
A case series of patients with β-thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies 105
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study 105
Paraoxonase-1 status in patients with hereditary hemochromatosis. 105
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease 105
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study 103
Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis 103
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 102
Impact of natural Neuromedin-B receptor variants on iron metabolism 96
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? 95
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 91
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 87
Hemochromatosis classification: update and recommendations by the BIOIRON Society 85
Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study 82
Inflammation and iron homeostasis - what do blood tests mean? 79
New Insights into the Role of Ferroptosis in Cardiovascular Diseases 78
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study 76
ERFE regulation in sickle cell disease: complex but promising 76
Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments 76
The Role of Iron Staining in Myelodysplastic Syndromes: A Treasure Trove of Information 70
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia 58
Sparing unnecessary transfusions through patient blood management: time for application also in internal and emergency medicine 56
Manipulating hepcidin in polycythemia vera 51
Recent Advancement of Hematology: Know, How to Do, Let Know 47
Recent Advancements in Hematology: Knowledge, Methods and Dissemination-1 47
Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry 8
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 6
Red blood cell distribution width and blood transfusions are associated with 2-year mortality after transcatheter aortic valve implantation in males but not in females: sex-related differences in hematological predictors 3
Diagnostics: Markers of Body Iron Status 2
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia 2
Characterization of ferroportin disease and SLC40A1-related hemochromatosis – Results from the EASL non-HFE registry 2
null 1
Totale 10.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.155
article - articoli 26.499
book - libri 0
conference - conferenze 8.110
curatela - curatele 0
other - altro 502
patent - brevetti 0
selected - selezionate 0
volume - volumi 44
Totale 70.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 0 0 25
2021/2022530 15 159 3 63 20 23 7 28 20 17 50 125
2022/20231.143 67 132 94 198 100 254 22 87 139 4 24 22
2023/2024665 21 36 49 58 54 149 21 48 7 32 96 94
2024/20251.570 82 111 65 255 71 50 94 71 195 94 150 332
2025/20265.031 321 267 356 909 1.332 260 394 235 375 272 90 220
Totale 10.600